Oct-02-20 Upgrade
BofA Securities
Underperform → Neutral
$54 → $58
Jul-02-20 Upgrade
Jefferies
Hold → Buy
$42 → $50
Jul-02-20 Upgrade
DA Davidson
Neutral → Buy
Mar-09-20 Downgrade
Deutsche Bank
Buy → Hold
$40 → $28
Dec-05-19 Resumed
Citigroup
Neutral
Nov-06-19 Downgrade
Citigroup
Buy → Neutral
Oct-30-19 Upgrade
Stifel
Sell → Hold
$38.50 → $45
Jul-17-19 Downgrade
Jefferies
Buy → Hold
$40
Jul-17-19 Downgrade
DA Davidson
Buy → Neutral
$38
Jun-19-19 Reiterated
BofA/Merrill
Underperform
$57 → $52
May-01-19 Upgrade
Deutsche Bank
Hold → Buy
May-01-19 Reiterated
BofA/Merrill
Underperform
$52 → $57
Apr-12-19 Reiterated
BofA/Merrill
Underperform
$65 → $52
Mar-25-19 Downgrade
Stifel
Hold → Sell
$63 → $43
Dec-06-18 Reiterated
BofA/Merrill
Underperform
$75 → $65
Oct-10-18 Initiated
DA Davidson
Buy
$92
Aug-03-18 Upgrade
Stifel
Sell → Hold
$57 → $70
Jun-14-18 Initiated
Jefferies
Buy
$98
Feb-16-18 Reiterated
Stifel
Sell
$50 → $57
Jan-23-18 Reiterated
Citigroup
Buy
$70 → $81
Jan-25-21 11:40AM
Jan-22-21 11:50AM
Jan-20-21 03:47AM
Jan-19-21 04:05PM
Jan-14-21 07:00AM
Jan-11-21 12:10PM
11:30AM
09:43AM
Jan-08-21 08:21AM
Jan-06-21 04:05PM
11:50AM
11:40AM
Dec-30-20 04:00PM
Dec-29-20 02:54PM
Dec-28-20 04:44AM
Dec-19-20 08:03PM
Dec-17-20 07:30AM
Dec-08-20 03:22AM
Dec-04-20 11:31AM
Dec-03-20 10:39AM
Nov-25-20 10:00AM
09:42AM Investor's Business Daily
Nov-24-20 12:53PM
08:05AM
04:07AM
Nov-20-20 12:45PM
Nov-18-20 11:50AM
11:40AM
11:30AM
Nov-17-20 10:16AM
Nov-16-20 07:58AM
Nov-10-20 08:12AM
Nov-06-20 08:41AM
Nov-05-20 10:29AM
Nov-04-20 06:35PM
04:42PM
04:06PM
04:05PM
Nov-03-20 09:38AM
Nov-02-20 11:50AM
11:40AM
11:30AM
10:07AM
07:25AM
Oct-30-20 11:00AM
Oct-29-20 11:25AM
Oct-28-20 12:32PM
Oct-27-20 10:48AM
Oct-26-20 11:17AM
09:15AM
Oct-22-20 10:43AM
Oct-21-20 10:25AM
Oct-20-20 09:46AM
Oct-19-20 12:00PM
11:17AM
Oct-15-20 11:40AM
Oct-14-20 11:50AM
Oct-13-20 07:51AM
Oct-08-20 12:10PM
Oct-05-20 10:16AM
08:56AM
08:14AM
Oct-02-20 07:21AM
Oct-01-20 04:50PM
Sep-30-20 09:35AM
Sep-29-20 12:22PM
11:40AM
Sep-28-20 11:30AM
10:03AM
Sep-23-20 11:16AM
Sep-22-20 09:30AM
Sep-17-20 11:00AM
Sep-16-20 12:00PM
Sep-14-20 09:21AM
Sep-11-20 01:21PM
11:40AM
Sep-10-20 11:30AM
Sep-08-20 10:51AM
Sep-04-20 11:31AM
Aug-26-20 11:40AM
Aug-22-20 09:11AM
Aug-20-20 09:58AM
07:00AM
Aug-19-20 11:30AM
Aug-11-20 09:06AM
Aug-10-20 11:50AM
11:40AM
Aug-06-20 12:08PM
Aug-05-20 07:25PM
05:46PM
04:06PM
04:05PM
01:46PM
Jul-31-20 01:14PM
Jul-30-20 12:13PM
11:57AM
10:41AM
Jul-29-20 12:33PM
Jul-21-20 11:40AM
Jul-17-20 08:16AM
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
NAPIERSKI RYAN S President Jan 20 Option Exercise 30.63 8,400 257,292 83,656 Jan 20 06:09 PM NAPIERSKI RYAN S President Jan 20 Sale 59.12 10,156 600,423 73,500 Jan 20 06:09 PM NAPIERSKI RYAN S President Jan 15 Option Exercise 30.63 7,000 214,410 82,256 Jan 19 06:24 PM NAPIERSKI RYAN S President Jan 15 Sale 55.45 7,000 388,150 75,256 Jan 19 06:24 PM NAPIERSKI RYAN S President Jan 07 Option Exercise 30.63 1,600 49,008 80,100 Jan 08 05:21 PM NAPIERSKI RYAN S President Jan 07 Sale 59.05 4,844 286,038 75,256 Jan 08 05:21 PM DORNY D MATTHEW General Counsel Jan 04 Option Exercise 30.63 6,200 189,906 50,573 Jan 04 07:19 PM DORNY D MATTHEW General Counsel Jan 04 Sale 55.02 6,200 341,133 44,373 Jan 04 07:19 PM NAPIERSKI RYAN S President Dec 15 Option Exercise 30.63 7,000 214,410 85,500 Dec 15 05:09 PM NAPIERSKI RYAN S President Dec 15 Sale 50.97 7,000 356,790 78,500 Dec 15 05:09 PM DORNY D MATTHEW General Counsel Dec 01 Option Exercise 30.63 6,200 189,906 50,573 Dec 02 04:55 PM Lawrence Mark H Chief Financial Officer Dec 01 Sale 50.61 3,993 202,086 48,526 Dec 02 04:52 PM DORNY D MATTHEW General Counsel Dec 01 Sale 50.81 6,200 314,996 44,373 Dec 02 04:55 PM NAPIERSKI RYAN S President Nov 16 Option Exercise 30.63 7,000 214,410 88,500 Nov 17 05:00 PM NAPIERSKI RYAN S President Nov 16 Sale 51.99 7,000 363,930 81,500 Nov 17 05:00 PM DORNY D MATTHEW General Counsel Nov 11 Option Exercise 30.63 6,200 189,906 51,873 Nov 12 04:06 PM DORNY D MATTHEW General Counsel Nov 11 Sale 51.14 6,200 317,063 45,673 Nov 12 04:06 PM NAPIERSKI RYAN S President Oct 15 Option Exercise 30.63 7,000 214,410 88,500 Oct 19 04:41 PM NAPIERSKI RYAN S President Oct 15 Sale 54.53 7,000 381,708 81,500 Oct 19 04:41 PM NAPIERSKI RYAN S President Oct 02 Option Exercise 30.63 10,000 306,300 91,500 Oct 05 04:35 PM NAPIERSKI RYAN S President Oct 02 Sale 54.47 10,000 544,650 81,500 Oct 05 04:35 PM NAPIERSKI RYAN S President Sep 24 Option Exercise 30.63 17,000 520,710 103,500 Sep 25 06:29 PM NAPIERSKI RYAN S President Sep 24 Sale 51.18 22,000 1,125,960 81,500 Sep 25 06:29 PM DORNY D MATTHEW General Counsel Sep 23 Option Exercise 30.63 6,200 189,906 51,873 Sep 25 06:57 PM DORNY D MATTHEW General Counsel Sep 23 Sale 51.71 6,200 320,599 45,673 Sep 25 06:57 PM CHANG JOSEPH Y Chief Scientific Officer Sep 10 Option Exercise 39.51 1,761 69,577 21,683 Sep 10 07:15 PM CHANG JOSEPH Y Chief Scientific Officer Sep 10 Sale 50.87 6,869 349,423 14,814 Sep 10 07:15 PM CHANG JOSEPH Y Chief Scientific Officer Sep 09 Option Exercise 39.51 5,039 199,091 29,853 Sep 10 07:15 PM CHANG JOSEPH Y Chief Scientific Officer Sep 09 Sale 49.92 9,931 495,756 19,922 Sep 10 07:15 PM NAPIERSKI RYAN S President Aug 17 Sale 47.24 5,000 236,200 86,500 Aug 18 04:05 PM CHANG JOSEPH Y Chief Scientific Officer Jun 05 Sale 40.01 34,970 1,399,150 37,882 Jun 08 07:12 PM WOOD RITCH N Chief Executive Officer Mar 20 Buy 20.25 10,000 202,500 153,192 Mar 23 04:38 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite